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Summary
In development and differentiation, morphological changes
often accompany mechanical changes [1], but it is unclear
whether or when cells in embryos sense tissue elasticity.
The earliest embryo is uniformly pliable, while adult tissues
vary widely in mechanics from soft brain and stiff heart to
rigid bone [2]. However, cell sensitivity to microenvironment
elasticity is debated based in part on results from complex
three-dimensional culture models [3]. Regenerative cardiol-
ogy provides strongmotivation to clarify any cell-level sensi-
tivities to tissue elasticity because rigid postinfarct regions
limit pumping by the adult heart [4]. Here, we focus on
the spontaneously beating embryonic heart and sparsely
cultured cardiomyocytes, including cells derived from
pluripotent stem cells. Tissue elasticity, Et, increases daily
for heart to 1–2 kPa by embryonic day 4 (E4), and although
this isw10-fold softer than adult heart, the beating contrac-
tions of E4 cardiomyocytes prove optimal at wEt,E4 both
in vivo and in vitro. Proteomics reveals daily increases in
a small subset of proteins, namely collagen plus cardiac-
specific excitation-contraction proteins. Rapid softening of
the heart’s matrix with collagenase or stiffening it with enzy-
matic crosslinking suppressesbeating. Sparsely culturedE4
cardiomyocytes on collagen-coated gels likewise show
maximal contraction on matrices with native E4 stiffness,
highlighting cell-intrinsic mechanosensitivity. While an
optimal elasticity for striation proves consistent with the
mathematics of force-driven sarcomere registration, con-
traction wave speed is linear in Et as theorized for excita-
tion-contraction coupled to matrix elasticity. Pluripotent
stemcell-derived cardiomyocytes alsoprove to bemechano-
sensitive to matrix and thus generalize the main observation
that myosin II organization and contractile function are opti-
mally matched to the load contributed by matrix elasticity.
Results and Discussion
The heart is the first functional organ in vertebrate embryos. It
beats spontaneously as a heart tube byw36 hr after fertiliza-
tion (Figure 1A). Subsequent stiffening has been described
thus far in terms of changes in cell volume, hyaluronic acid,*Correspondence: discher@seas.upenn.eduand/or collagen I [5], but functional evaluations of such
changes have been lacking. Cardiomyocytes isolated from
either late embryos [6, 7] or neonates [8–10] and cultured on
substrates of varied stiffness suggest that gels that are stiffer
than adult heart suppress contraction. Extremely soft sub-
strates suppress sarcomere organization and limit contractile
ability, with additional evidence of altered cytoskeletal confor-
mation and assembly [6] in the absence of changes in mecha-
nosensitive degradation [11] or transcription [12] that are
evident in other cells. Mature cells cultured on gels can thus
exhibit an optimal stiffness for contraction, but relevance of
matrix elasticity to intact heart remains unclear and controver-
sial based on a handful of culture studies (e.g., [3]).
Heart Stiffens with Expression of Excitation-Contraction
and Collagen Proteins, whereas Brain Remains Soft
Tissue aspiration into micropipettes (Figure 1B) of diameter
sufficient to probe dozens of cells plus extracellular matrix [1]
shows that heart at all stages behaves elastically (Figure 1C),
whereasmidbrain tissue and embryonic disk flowoverminutes
and fail to recover fully after release of the applied stress. The
effective Young’s modulus of each tissue, Et, was calculated
from the slope of aspiration pressure versus aspirated length
(see Figure S1A available online) [13], and for brain and embry-
onicdisc, the (already large) aspirated lengthat 2minwasused.
By E2, the presumptive ventricle is already 3-fold stiffer than
undifferentiated embryonic disc and embryonic brain. The
latter remains roughly constant through development at 0.3 6
0.2 kPa (Figure 1D) andmatches adult brain stiffness [14]. Brain
tissue is thus always soft, whereas heart stiffens up to about
10-fold to reach neonate and adult heart stiffness by wE14
[6]. Modest stiffness variations of 620% along the heart tube
(Figure S1B) are also consistent with past reports [15].
Expression trends for at least some tissue proteins seemed
likely to parallel the divergent trends in tissue mechanics and
to confer tissue stiffness. Quantitative mass spectrometry of
extracts from embryonic discs and E2–E4 and E10 heart and
brain tissue identified over 200 diverse proteins (Table S1), of
which fewer than 10% followed trends in expression similar
to those of Et (Figures 1D–1H, S1C, and S1D). Most trend-
following proteins related closely to the excitation-contraction
coupling system, such as cardiac actomyosin contractile
proteins, adhesion proteins, and the sarcoplasmic calcium
channel SERCA. Mitochondrial proteins (relevant to ener-
getics) also followed the trends, but with smaller differences
between heart and brain. Proteins that were notably uncorre-
lated with tissue stiffness included many nuclear proteins,
intermediate filament proteins, and nonmuscle myosin. Of
two extracellular matrix (ECM) proteins detected, fibronectin
and collagen I, only collagen I follows the Et trends.
To begin to assess stiffness contributions of the actomyosin
cytoskeleton or collagen, we inhibited myosin contractility
with the myosin II ATPase inhibitor blebbistatin or else disrup-
ted the collagenous ECM with mild collagenase treatments
and then measured tissue stiffness. With blebbistatin, heart
tissue from E2 to E14 is softened by w25% and brain tissue
byw50% (Figure S1E). In contrast, collagenase had no signif-
icant effect on brain tissue but considerably softened both
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Figure 1. Mechanical Development of Heart and Brain Tissue Parallels Expression of Abundant Cell and Matrix Proteins
(A) E3 chick embryo with heart tube (white box) and midbrain (blue box) in situ and after isolation. The heart continues to beat ex vivo, with contraction and
flow propagating along the dashed line. Scale bar represents 100 mm.
(B) Micropipette aspiration of an E3 heart tube in phase-contrast microscopy using pipettes that are much larger in diameter than single cells. Scale bar
represents 10 mm.
(C) Representative aspiration and relaxation curves for E4 heart and brain demonstrate the respective elastic and inelastic responses.
(D) Et for heart and brain tissue throughout embryonic development, starting with day 1 embryonic disk, then E2, E4, E6, and E14 heart and brain (nR 3
measurements each). By the time beating starts, the heart is already 3-fold stiffer than early embryonic tissue and then stiffens at a rate of 0.3 kPa/day.
Due to the thick epicardium of E6 and older hearts relative to the inner diameter of our micropipettes, measurements likely underestimate stiffness of
the myocardium at those stages due to significant contribution of epicardium. Brain tissue does not stiffen during development and remains viscoelastic
with a mean Et = 0.3 kPa.
(E) Quantitative mass spectrometry (MS) of cellular proteins extracted from intact embryonic disc (Hamburger-Hamilton stages 3–4), E2, E3, E4, and E10
heart and brain tissue reveals a small set of detected proteins with expression patterns similar to heart or brain mechanics: namely, a general increase
in heart and relatively small increase in brain. Expression is relative to average in brain E2–E3 (nR 3 MS measurements).
(F) Immunoblot confirms that MS measurements of cardiac myosin II expression increase in heart development. Samples are pooled from three to four
embryos at each reported stage and were normalized to lamin-B1 (nR 3).
(G) MS indicates that collagen I expression increases during heart development, but not greatly during brain development. Inset images: 1% SDS-decellu-
larized E4 and E14 hearts. The insoluble matrices retain the shape of the embryonic hearts, but whereas E14 matrix (with 80% of MS ion current being
collagen I) appears solid, the E4 matrix appears more reticulated and porous, consistent with relatively less mass.
(H) Of the proteins identified byMS (Table S1), a small subset had expression levels across tissues and development that paralleledmechanics. Error bars in
all figures represent SEM.
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2435early and late heart (Figure S1F), without perturbing myosin II
levels (Figure S1G). The stiffness of brain tissue thus seems
cellular in nature, whereas heart tissue mechanics have major
extracellular matrix contributions at even the earliest func-
tional stage of beating.
Modest Softening or Stiffening Impairs Beating
Embryonic heart tubes beat spontaneously atw1 Hz for up to
1–2 days after isolation, and we could easily measure local tis-
sue strain in heart tubes during beating by imaging GFP-trans-
fected cells as fiducial markers (Figure 2A). This very visible
activity is used to address the main question of our studies:
whether cells in an intact living tissue are sensitive tomicroenvironment elasticity. Controlled dose-time treatments
with collagenase provided a simple means of softening tissue
matrix (in only 30 min), while enzymatic crosslinking of ECM
with transglutaminase provided a similarly rapid method to
stiffen tissue (Figures S2A and S2B). Enzyme permeated the
tissue (Figure S2C), and for all but the most extreme softening
treatment, embryonic heart behaved elastically in micropi-
pette aspiration (Figure S2B, inset). By transfecting cells with
a GFP membrane protein (SIRPA-GFP), we could also see
that the contours of beating cells were unaffected by collage-
nase (Figures 2B and S2D). Tissue softening is thus due
primarily to cleavage of ECM rather than disruption of cell
connections.
A∆s12
∆s1’2’
B
Relaxed
Contracted
C
Strain in Ventricle = 
0.10 – 0.15
0
1
Local Heart 
contraction
S
tra
in
tre
at
ed
/ S
tra
in
un
tre
at
ed
E
very lowEo
0
30
0 1 2 3
Velocity 
through 
ventricle
V
el
oc
ity
 (m
m
/s
)
E4 Heart stiffness:  Etreated / Euntreated
E4 hearts
Contraction
Before 
treatment
Collagenase
1 2 3 4
2 3 3  4
30 mini ii iii
iv
v
0
1
2
0 50
R
el
at
iv
e 
st
iff
ne
ss
Softening time (min)
10-30
D
N
on
be
at
in
g 
 +
  P
ar
tia
l-
be
at
in
g 
fra
ct
io
n 
of
 h
ea
rts
Partial-
beating0
1
Aspiration
heart contours
*
E6 hearts
Figure 2. Effect of Extracellular Matrix Softening
and Stiffening on Heart Tube Beating
(A) E4 heart imaged by phase contrast (i) or fluo-
rescence (ii) after sparse transfection with GFP.
Scale bar represents 100 mm. Each green spot
is a cell. Three cells used to calculate strain dur-
ing beating are tracked from their relaxed (iii) to
contracted (iv) positions. Scale bar represents
20 mm. Strain is schematized in (v).
(B) SIRPA-GFP-expressing cell in transfected
E4 heart tissue before and after softening.
Overlays of SIRPA-GFP-expressing cells over
time help visualize cell shape changes during
contraction and softening treatments. Overlay
of the same cell pretreatment while relaxed
(green) and contracted (red) (bottom left)
shows less overlap (yellow) than the relaxed
cell before and after tissue softening; cells
thus maintain morphology and adhesions dur-
ing softening.
(C) Tissue strain during beating of GFP-trans-
fected softened and stiffened E4 heart normal-
ized to that of untreated and the resulting relative
strain averaged for atria, ventricles, and outflow
tract: softened and stiffened tissues suppress
contractions. Typical peak strains throughout
the untreated heart tube were 10% 6 4%. The
dashed curve is a fit to Equation 1 with exponent
n = 4 6 1 and Em = 1.6 6 0.2 kPa.
(D) E6 hearts treated progressively with collage-
nase stop beating or beat only partially. Beating
is suppressed after 50 min softening treatment,
relative to untreated or briefly (10–30 min) treated
hearts (p = 0.016). Insets: representative aspira-
tion-relaxation curves for mildly softened or considerably softened hearts. Red indicates untreated tissue; blue indicates treated tissue.
(E) Velocity of the contraction wave through the ventricle versus normalized Et. Wave speeds in untreated ventricle, atria, and outflow tract of 226 4, 46 2,
and 2.8 6 0.7 mm/s, respectively, are consistent with past work [16]. For the most extreme stiffening treatment, contraction does not propagate past the
presumptive pacemaker. The dashed line is the theoretical prediction with a single adjustable parameter, namely the ratio of the stress threshold to the
magnitude of the force dipole corresponding to a contracting cell. Eo indicates the theoretically predicted stiffness below which a contraction wave should
not propagate. Error bars for all figures represent SEM (nR 3 hearts).
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2436After the enzymatic treatments, hearts continue to beat
rhythmically (Movie S1), but themagnitude of local contraction
(calculated from GFP-expressing cells) was always affected.
Each heart tube region was analyzed separately (Figures
S2E–S2I), and normalization to pretreatment measurements
accounted for slight variations (w20%) in embryo age and/or
lab temperature. Untreated tissue invariably showed the
largest contraction, which was typically w10% strain, while
both softening and stiffening of the heart suppressed contrac-
tile strain (Figures 2C and S2E). Stiffening of tissue should sup-
press strain because any muscle cell has a finite capacity to
work against a very high load, but softening of the tissuematrix
also decreased contractile strain. Consistent with these E4
results, softening of E6 hearts likewise impeded beating
(Figure 2D). A mathematical theory for striation [17] provides
a basis for modeling contractile functions with the equation
fw
h
E=ðEm +EÞ2
in
; (Equation 1)
which also fits contractile strains in experiments (Figure 2C,
dashed line; Box S1). The optimal stiffness for heart contrac-
tion is thus the stiffness of native heart.
The speed of the contraction wave in each heart region
increases monotonically with tissue stiffness, except for the
most extreme rigidity (Figure 2E). The linearity of wave speed
can be predicted from a viscoelastic model of active media
(Box S2). For the rigidified heart, beating was still evident,
but the contraction wave did not propagate past thepacemaker region in the atrium (Figure S2I). Softening treat-
ments also decreased the probability of contractions propa-
gating out of the atrium.
E4 and Stem Cell-Derived Cardiomyocytes Are Highly
Sensitive to Matrix Elasticity
To assess whether variations in matrix elasticity affect
E4-cardiomyocyte adhesion and beating, isolated cells and
their properties were studied as sparse cultures on collagen
I-coated polyacrylamide gels of varied stiffness (Figure 3A).
Most of the cultured cells beat at 0.5–1.5 Hz, similar to the
heart, indicating high viability as well as sustained adhesion.
Relaxed morphologies were measured after 24 hr in culture
and showed that substrates stiffer than E4 heart tissue pro-
mote spreading and elongation (Figure S3A), as is common
with other mesenchymal cell types (e.g., [12]). Cells on
matrices of stiffness similar to that of the tissue of origin
(w1–2 kPa) were relatively round and unspread compared to
the maximum achievable elongation and spreading. Nonethe-
less, contractile deformation of an E4 cardiomyocyte and its
local matrix proves optimal at the matrix elasticity of native
E4 tissue (Figure 3B). In vitro contractions were measured in
terms of both 2D strains using cell edge displacements and
changes in aspect ratio.
Cardiomyocytes derived from embryonic stem cells (ESC-
CM), induced pluripotent stem cells (iPS-CM), or directly
transdifferentiated cells hold great potential for regenerative
therapies [18], and human ESC-CM and iPS-CM displace
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Figure 3. Isolated Cardiomyocytes Are Sensitive
to Matrix Stiffness, with Striation Dependent on
Actomyosin Work
(A) Cardiomyocytes were imaged beating in cul-
ture after 18–24 hr in culture. Morphologies in
the relaxed and contractile states and contractile
strains were measured for beating cells.
(B) Edge strain of cardiomyocytes cultured on PA
gels of various stiffnesses, measured as the trace
of the 2D strain matrix of cell edge points during
beating, as described in Supplemental Experi-
mental Procedures. In beating, cell and matrix
strain are strongly modulated by substrate elas-
ticity with an optimal Egel similar to that of E4
heart and much lower than that measured for
more mature cells ([6, 8]). Softer and stiffer
substrates impede beating of cultured cells. The
Lorentzian fit gives Em = 1.36 0.3 kPa, consistent
with the tissue elasticity of E4 hearts (Et = 1.3 6
0.4 kPa in Figure 1).
(C and D) Representative image of E7 cardio-
myocytes recovering from latrunculin A (Lat-A)
treatment in the presence (C) or absence (D)
of blebbistatin, which does not affect cell
viability [12].
(E) Myofibril assembly was measured as the per-
centage of cell area covered by mature myofibrils
(sarcomere spacing > 1.5 mm). Inhibition of
beating and actomyosin contractility by bleb-
bistatin reduces the amount of new myofibrils
formed following Lat-A washout and causes
mature myofibrils to disassemble per (C). Inset
shows that for these late embryo cardiomyo-
cytes, the optimal elasticity for rapid recovery of
striated premyofibrils is close to that of adult
heart (Et w 10–15 kPa). Error bars are SEM (n R
3 cells). *p < 0.05.
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2437soft matrix more than stiffer matrix [19]. Here, ESC-CM on soft,
intermediate, and stiff substrates that match immature (1 kPa),
mature (11 kPa), and diseased (34 kPa)myocardium express at
day 4 in culture similar levels of sarcomeric proteins, but
myofibril organization is visibly optimal for intermediate stiff-
ness, and contracting edge velocities decrease with substrate
stiffness (Figures S3B–S3E). On soft substrates in day 6 cul-
tures, myofibrils decrease and beating stops, whereas ESC-
CM on the intermediate and stiff substrates bifurcated into
either fast or slow contracting cell populations. Cardiogenesis
is thus generally sensitive to matrix mechanics.
Optimal Striation Depends onMyosin II Contractile Activity
Organization of the actomyosin cytoskeleton into sarcomeres
andmyofibrils within striatedmuscle cells is a well-established
determinant of contractile activity [6, 8, 9], but in living
zebrafish, fluorescence recovery after photobleaching showsstriation proteins are mobile on time-
scales of 1–10min [20]. Cardiomyocytes
treated with the myosin II ATPase
inhibitor blebbistatin do not beat even
though calcium transients are unaf-
fected [21], and cells beat again within
seconds after drug washout [22]. This
is far quicker than contractility re-
sponses to heart matrix alterations in
the 0.5–2 hr treatments here. To assess
a role for myosin II activity and contrac-
tile forces in striation as assumed in themodeling here [17] (Box S1), we grew E7 cells with abundant
striation on gels optimal for striation [6], pulsed them for
30 min with latrunculin to disassemble myofibrils, and then
added blebbistatin to half of the cultures (Figures 3C and
3D). In the absence of blebbistatin, both premyofibrils and
maturemyofibrils recovered over a few hours from the induced
disassembly, and most cells were filled with striations after
24 hr (Figures 3D and 3E), whereas sustained blebbistatin
suppressed striation, consistent with striation requiring active
myosin II.
Myofibril Order Depends on Matrix Elasticity
With E4 hearts, we sought to quantify any possible striation
differences with and without matrix alterations. Sarcomeric
a-actinin-2 is a key crosslinker of ‘‘z bands’’ that is seen in
mature myofibrils within embryos and also in shorter-period
premyofibrils using deconvolution microscopy [23]. In our
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Figure 4. Sarcomere Breadth Changes in Soft-
ened Heart and in Isolated Cardiomyocytes on
Compliant Substrates
(A) Untreated and softened whole E4 hearts
were immunostained for sarcomeric a-actinin-2,
F-actin, and DNA and imaged by confocal micro-
scopy. Sarcomere spacing and z band breadth
(inset) were measured to assess any structural
changes.
(B) z band breadth is significantly decreased in
the 47%-softened heart relative to untreated con-
trols. The decreased registry of myofibrils sug-
gests a decreased coupling between adjacent
myofibrils during contraction. Sarcomere spacing
(lower plot) is consistent with mature myofibril
sarcomere spacing and is not significantly
different in softened and untreated hearts.
(C) E4 cardiomyocytes cultured on gels were
stained in the same manner as the whole hearts
in (A). Figure shows typical E4 cardiomyocytes
on gels with stiffnesses of 0.3, 3.0, and 10 kPa.
(D) Striation spacing was bimodal in distribution,
indicating mature myofibrils (sarcomere spac-
ing > 1.8 mm) as well as premyofibrils (sarcomere
spacing < 1.4 mm).
(E) Fraction of each type of striation per cell with
myofibrils maximal on gels where premyofibrils
are minimal. We fit the fraction of myofibrils with
fm = f (Equation 1) (blue dashed line) and premyo-
fibrils using fp = 1 2 fm with Em = 9 6 2 kPa.
(F) z band breadth for myofibrils and premyofi-
brils were maximized on substrates of intermedi-
ate stiffness. Fits to Equation 1 yield Em = 1.7 6
0.3 kPa for premyofibrils and Em = 4.2 6 0.6 kPa
for myofibrils.
Error bars are SEM (nR 3 hearts or cells).
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2438confocal imaging, we measured sarcomere spacing lateral
‘‘breadth’’ of z bands along in-plane sarcomeres as a key
metric of registry (Figure 4A, inset). Whereas striation spacing
peaked at 1.8 mm and appeared unaffected by w50% soft-
ening of the E4 heart, z band breadth was reduced relative to
untreated control (Figure 4B). This decreased registry of myo-
fibrils shortly after softening of the matrix indicates a
decreased coupling of sarcomeres and is consistent with the
striationmodel [17], highlighting amolecular-scalemechanism
for decreased contraction against decreased extracellular
load.
Isolated cardiomyocytes beating on gels (Figure 4C) show
striation spacing ofw1 mm for premyofibrils, which conforms
to expectations [20], and also the typicalw1.9 mm spacing of
myofibrils (Figure 4D) evident in intact heart. Striation spacing
shows no variation with matrix, but the abundance of myofi-
brils relative to premyofibrils is maximized on matrices of
elasticity 2–10 kPa (Figure 4E). This is consistent with myofi-
bril assembly from premyofibrils [20]. The z band breadth of
myofibrils also exhibited a broad and significant (p < 0.05)
maximum (atw2 mm breadth) within a similar range of matrix
elasticities that promote myofibril formation (Figure 4F).
The premyofibrils exhibited a somewhat narrower (w1.5 mm)
z band breadth that decreased on the stiffest substrates.Myofibril structural trends in response
to substrate stiffness in culture are
thus consistent with intact E4 heart
and suggest a common mechanism of
stiffness-dependent registration.z band breadth results for both mature myofibrils and
premyofibrils (Figure 4F) were also fit by Equation 1 with
respective Em = 4.2 6 0.6 and 1.7 6 0.3 kPa (n = 0.24 6 0.1).
Differences in Em suggest that myofibril organization favors a
stiffer matrix or higher load. However, z band breadth also
likely underestimates registration order within a cell, as it
only includes immediately adjacent and perfectly registered
striated fibers. Indeed, z band breadth trends for myofibrils
and premyofibrils in isolated cells are broader than in simula-
tion [17] but are still consistent with trends for intact heart
(Figures 4B and 4F). What emerges systematically from fitting
to Equation 1 is that n increases with length scale: the smallest
n is determined for z band breadth in culture, and the largest
n is found for strain in the intact heart. High cell density, 3D
cell-matrix coupling, and cell-cell signaling in tissue (including
calcium excitation waves) could all provide a basis for the
enhanced sensitivity to matrix E of tissue.
Protein interactions that govern molecular mobility are force
sensitive in living cardiomyocytes and vary with matrix
elasticity [6]. An optimum stiffness for striation is thus under-
standable: while contractile activity ‘‘massages’’ registration
(Figures 3E and 4) and these forces increase with matrix stiff-
ness [1], high forces on stiff matrix tend to break bonds [6].
Myofibrils thereby misregister if the load is either too low or
Beating Hearts Have Optimal Matrix and Myosin
2439high, which largely explains why parallel and optimal increases
in actomyosin proteins and collagens (Figure 1) must be coor-
dinated in the tissue development program. Invading and
proliferating fibroblasts make and remodel the matrix that
stimulates cardiomyocyte proliferation [24] with increased
expression of specialized contractile proteins (a-actinin-2,
cardiac myosin II in Figures 1D and 1E), and so it is sensible
that this program requires matrix engagement by integrins
[24] and extends tomechanosensitive, adhesion complex pro-
teins such as talin [25] that also increase (Figure 1D). More-
over, since collagen synthesis and organization by fibroblasts
are regulated by strain (as reviewed in [26]), heart matrix is
likely to be optimized by the optimal stiffness for cardiomyo-
cyte striation and contraction (Figures 2, 3, and 4). The fact
that the optimum increases in development from 1 to 2 kPa
at E4 toward the stiffness of adult heart (e.g., Figures 1C and
3E, inset) [6, 8, 9] is also consistent with preliminary observa-
tions that hearts that were stiffened and stopped beating
would sometimes restart their beating 10 hr later. Last, excita-
tion-contraction coupling (ECC) in muscle physiology is well
established [27], but the broad effects of matrix stiffness on
individual cells in sparse culture preclude the confounding
impacts of cell-cell electrical communication and ultimately
suggest that excitation-contraction-matrix coupling (ECMC)
is required to truly understand muscle.
Experimental Procedures
Heart isolation (per IACUC-approved protocol 804455), enzyme treatments,
micropipette analyses, tissue strain analyses, mass spectrometry prote-
omics, cell isolation, and standard techniques are described in detail in
the Supplemental Experimental Procedures.
Supplemental Information
Supplemental Information includes three figures, two boxes, Supplemental
Analysis, Supplemental Experimental Procedures, one table, and onemovie
and can be found with this article online at http://dx.doi.org/10.1016/j.cub.
2013.10.057.
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